| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
62,132 |
51,444 |
$3.86M |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
22,896 |
13,862 |
$1.74M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
36,118 |
32,047 |
$1.63M |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
24,538 |
7,040 |
$647K |
| G6015 |
Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session |
1,975 |
475 |
$542K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
33,139 |
19,150 |
$529K |
| Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) |
690 |
422 |
$430K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
5,633 |
3,022 |
$407K |
| 99215 |
Prolong outpt/office vis |
5,493 |
4,184 |
$385K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
7,968 |
4,981 |
$316K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
2,523 |
2,409 |
$309K |
| Q5107 |
Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg |
167 |
63 |
$262K |
| J1453 |
Injection, fosaprepitant, 1 mg |
3,037 |
1,696 |
$248K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
77,117 |
58,987 |
$247K |
| 80053 |
Comprehensive metabolic panel |
49,752 |
40,877 |
$207K |
| 99233 |
Prolong inpt eval add15 m |
2,936 |
1,175 |
$175K |
| 99223 |
Prolong inpt eval add15 m |
1,457 |
1,302 |
$158K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
13,730 |
8,922 |
$151K |
| 77014 |
|
1,654 |
380 |
$142K |
| 77427 |
|
908 |
478 |
$99K |
| 96367 |
|
4,800 |
2,958 |
$88K |
| J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) |
95 |
57 |
$85K |
| 96417 |
|
2,207 |
1,269 |
$85K |
| 96416 |
|
667 |
395 |
$68K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,838 |
1,065 |
$63K |
| 82728 |
|
9,295 |
8,626 |
$55K |
| 82378 |
|
4,672 |
4,081 |
$39K |
| J0185 |
Injection, aprepitant, 1 mg |
219 |
97 |
$36K |
| J9190 |
Injection, fluorouracil, 500 mg |
1,591 |
811 |
$32K |
| 83615 |
|
12,212 |
10,166 |
$30K |
| 36415 |
Collection of venous blood by venipuncture |
34,362 |
27,469 |
$25K |
| 83550 |
|
6,843 |
6,433 |
$23K |
| 76641 |
|
279 |
261 |
$23K |
| J1750 |
Injection, iron dextran, 50 mg |
205 |
127 |
$23K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
21,305 |
12,126 |
$21K |
| 99222 |
Initial hospital care, per day, moderate complexity |
407 |
303 |
$20K |
| 83540 |
|
7,431 |
6,968 |
$20K |
| 94060 |
|
558 |
514 |
$18K |
| J9263 |
Injection, oxaliplatin, 0.5 mg |
236 |
116 |
$18K |
| 86300 |
|
1,834 |
1,630 |
$18K |
| 96415 |
|
781 |
480 |
$18K |
| 77336 |
|
365 |
203 |
$17K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,398 |
1,324 |
$17K |
| J3490 |
Unclassified drugs |
606 |
176 |
$15K |
| Q5101 |
Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram |
63 |
38 |
$13K |
| 99205 |
Prolong outpt/office vis |
91 |
87 |
$13K |
| 82607 |
|
1,975 |
1,882 |
$13K |
| J1756 |
Injection, iron sucrose, 1 mg |
155 |
79 |
$10K |
| J0640 |
Injection, leucovorin calcium, per 50 mg |
261 |
121 |
$10K |
| 94729 |
|
216 |
199 |
$7K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
431 |
156 |
$5K |
| 94375 |
|
259 |
238 |
$5K |
| 82746 |
|
663 |
629 |
$4K |
| 96411 |
|
115 |
79 |
$4K |
| 84443 |
Thyroid stimulating hormone (TSH) |
617 |
586 |
$4K |
| 96521 |
|
43 |
28 |
$3K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
48 |
41 |
$3K |
| 94726 |
|
79 |
77 |
$3K |
| 84439 |
|
726 |
681 |
$3K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
639 |
600 |
$2K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
4,328 |
1,607 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
91 |
79 |
$2K |
| 80050 |
General health panel |
70 |
66 |
$2K |
| J1626 |
Injection, granisetron hydrochloride, 100 mcg |
548 |
174 |
$1K |
| 80076 |
|
398 |
381 |
$1K |
| 84436 |
|
414 |
400 |
$1K |
| 85652 |
|
964 |
874 |
$1K |
| J9206 |
Injection, irinotecan, 20 mg |
45 |
12 |
$939.76 |
| 94664 |
|
99 |
92 |
$885.05 |
| 96368 |
|
85 |
48 |
$853.75 |
| 84153 |
|
341 |
282 |
$722.48 |
| 94618 |
|
29 |
26 |
$557.48 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
42 |
28 |
$524.95 |
| 84481 |
|
42 |
42 |
$441.48 |
| 90674 |
|
27 |
19 |
$422.63 |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
14 |
12 |
$419.48 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
268 |
183 |
$293.81 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
973 |
893 |
$252.24 |
| 90686 |
|
24 |
17 |
$212.34 |
| 82784 |
|
32 |
14 |
$135.51 |
| 86334 |
|
15 |
14 |
$128.16 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
82 |
49 |
$116.20 |
| 82232 |
|
13 |
12 |
$77.88 |
| 84165 |
|
15 |
14 |
$61.59 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
95 |
12 |
$54.40 |
| J0461 |
Injection, atropine sulfate, 0.01 mg |
34 |
12 |
$42.54 |
| 85045 |
|
12 |
12 |
$30.78 |
| 82565 |
|
12 |
12 |
$28.25 |
| 84520 |
|
12 |
12 |
$24.37 |
| 85018 |
|
14 |
12 |
$14.64 |
| G0008 |
Administration of influenza virus vaccine |
17 |
14 |
$2.89 |
| G1007 |
Clinical decision support mechanism aim specialty health, as defined by the medicare appropriate use criteria program |
13 |
13 |
$0.00 |